Filing Details
- Accession Number:
- 0001179110-18-006502
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-09 19:26:47
- Reporting Period:
- 2018-05-08
- Accepted Time:
- 2018-05-09 19:26:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1017832 | P Martin Sutter | 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2018-05-08 | 25,000 | $13.91 | 191,377 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 700 | $340.47 | 190,677 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 400 | $342.00 | 190,277 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 2,757 | $342.79 | 187,520 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 3,950 | $343.77 | 183,570 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 1,400 | $344.69 | 182,170 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 400 | $345.64 | 181,770 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 283 | $346.54 | 181,487 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2018-05-08 | 12,000 | $18.63 | 193,487 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 800 | $340.42 | 192,687 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 200 | $341.84 | 192,487 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 2,700 | $342.67 | 189,787 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 5,300 | $343.66 | 184,487 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 1,900 | $344.55 | 182,587 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 700 | $345.38 | 181,887 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 400 | $346.26 | 181,487 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2018-05-08 | 6,546 | $329.01 | 188,033 | No | 4 | A | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2018-05-08 | 201,818 | $329.01 | 745,000 | No | 4 | D | Indirect | By Essex Woodland Health Ventures, VI, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | D | Indirect | By Essex Woodland Health Ventures, VI, LP |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2018-05-08 | 25,000 | $0.00 | 25,000 | $13.91 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-05-08 | 12,000 | $0.00 | 12,000 | $18.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-05-20 | 2018-05-20 | No | 4 | M | Direct |
| 0 | 2009-08-12 | 2018-08-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.01 Par Value | 503,182 | Indirect | By Essex Woodlands Health Ventures Fund VII, LP |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $7.67 | 2010-08-11 | 2019-08-12 | 12,000 | 12,000 | Direct |
| Common Stock | Stock Option (right to buy) | $9.99 | 2011-08-10 | 2020-08-11 | 12,000 | 12,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-08-12 | 12,000 | 12,000 | Direct |
| 2020-08-11 | 12,000 | 12,000 | Direct |
Footnotes
- These securities are held by Essex Woodlands Health Ventures Fund VI, L.P. Mr. Sutter is a managing director of Essex Woodlands Health Ventures, the partnership that owns the reported securities. As a managing director Mr. Sutter shares voting and investment powers for Essex Woodlands Health Ventures Fund VI, L.P.. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.
- These securities are held by Essex Woodlands Health Ventures Fund VII, L.P.. Mr. Sutter is a managing director of Essex Woodlands Health Ventures, the partnership that owns the reported securities. As a managing director Mr. Sutter shares voting and investment powers for Essex Woodlands Health Ventures Fund VII, L.P. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.
- Grant to reporting person to buy shares of Common Stock under ABIOMED, Inc. 2000 Stock Incentive Plan.
- These options become exerciseable in annual 20% increments commencing on the date set forth in Table II, Column 6.
- Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $340.3300 and $340.5700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $341.8400 and $342.2700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $342.3300 and $343.2900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $343.3400 and $344.1800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.3700 and $345.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.3500 and $345.7600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.4000 and $346.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $340.0000 and $340.5800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $342.1700 and $342.9700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $343.1500 and $343.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $344.0000 and $344.9900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $345.0000 and $345.7700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $346.0000 and $346.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- Transaction represents shares of common stock sold for the payment of the exercise price of stock options and withholding taxes associated with stock option exercise.
- Essex Woodlands Health Ventures VI LP made an in-kind distribution of 201,818 shares of Abiomed Stock, in which Mr. Sutter as a limited partner of Essex Woodlands Health Ventures VI LP received 6,546 shares.
Billionaire Hedge Funds
